Expression of mRNA for type IV collagen α1, α5 and α6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome

Matrix Biology

Volumn 17, Issue 4, 1998, Pages 279-291

  Sasaki, Satoshi ^a   Zhou, Bing ^a   Fan, Wei Wei ^a   Kim, Youngki ^a   Barker, David F ^b   Denison, Joyce C ^b   Atkin, Curtis L ^b   Gregory, Martin C ^b   Zhou, Jing ^c   Segal, Yoav ^c   Sado, Yoshikazu ^d   Ninomiya, Yoshifumi ^d   Michael, Alfred F ^a   Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Alport syndrome; Cultured fibroblasts; Mutation; Type IV collagen mRNA

Indexed keywords

COLLAGEN TYPE 4; MESSENGER RNA;

ADULT; ALPORT SYNDROME; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SKIN FIBROBLAST;

GLOMERULUS;

EID: 13144275247     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90081-6     Document Type: Article

References (52)

1. Alitalo, K., Kuismanen, E., Myllylä, R., Kiistala, U., Askoseljavaara, S. and Vaheri, A.: Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells. J. Cell Biol. 94: 497-505, 1982.
2. Barker, D.F., Hostikka, S.L., Zhou, J., Chow, E.T., Oliphant, A.R., Gerken, S.C., Gregory, M.C., Skolnick, M.H. and Atkin, C.L.: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224-1227, 1990.
3. Barker, D.F., Pruchno, C.J., Jiang, X., Atkin, C.L., Stone, E.M., Denison, J.C., Fain, P.R. and Gregory, M.C.: A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am. J. Hum. Genet. 58: 1157-1165, 1996.
4. Botstein, G.R., Shere, G.K. and Leroy, E.C.: Fibroblast selection in scleroderma: An alternative model of fibrosis. Arthritis Rheum. 25: 189-195, 1982.
5. Boyd, C.D., Toth-Fejel, S., Gadi, I.K., Litt, M., Condon, M.R., Kolbe, M., Hagen, I.K., Kurkinen, M., MacKenzie, J.W. and Magenis, E.: The genes coding for human pro alpha 1(IV) and pro alpha 2(IV) collagen are both located at the end of the long arm of chromosome 13. Am. J. Hum. Genet. 42: 309-314, 1988.
6. Butkowski, R.J., Wieslander, J., Kleppel, M., Michael, A.F. and Fish, A.J.: Basement membrane collagen in the kidney: Regional localization of novel chains related to collagen IV. Kidney Int., 35: 1195-1202, 1989.
7. Ding, J., Kashtan, C.E., Fan, W.W., Kleppel, M.M., Sun, M.J., Kalluri, R., Neilson, E.G. and Michael, A.F.: A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the α5 chain of type IV collagen. Kidney Int., 45: 1504-1506, 1994b.
8. Ding, J., Zhou, J., Tryggvason, K. and Kashtan, C.E.: COL4A5 deletions in three patients with Alport syndrome and post-transplant antiglomerular basement membrane nephritis. J. Am. Soc. Nephrol. 5: 161-168, 1994a.
9. Fleischmajer, R., Kühn, K., Sado, S., MacDonald, II D., Perlish, J.S., Pan, T-C., Chu, M-L., Kishiro, Y., Oohashi, T., Bernier, S.M., Yamada, Y. and Ninomiya, Y.: There is temporal and spatial expression of α1(IV), α2(IV), α5(IV) and α6(IV) collagen chains and β1 integrins during the development of the basal lamina in an "In Vitro " skin model. J. Invest. Dermatol. 109: 527-533, 1997.
10. Gregory, M.C. and Atkin, C.L.: Alport syndrome. In: Diseases of the Kidney, ed. by Schrier, R.W. and Gottschak, C.W., Little Brown, Boston, 1993, pp. 571-591.
11. Gubler, M.C., Knebelmann, B., Beziau, A., Broyer, M., Pirson, Y., Haddoum, F., Kleppel, M.M. and Antignac, C.: Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int., 47: 1142-1147, 1995.
12. Gupta, M.C., Graham, P.L. and Kramer, J.M.: Characterization of α1(IV) collagen mutations in Caenorhabditis elegans and the effects of α1and α2(IV) mutations on type IV collagen distribution. J. Cell Biol. 137: 1185-1196, 1997.
13. Hostikka, S.L., Eddy, R.L., Byers, M.G., Hoyhtya, M., Shows, TB. and Tryggvason, K.: Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc. Natl. Acad. Sci. USA 87: 1606-1610, 1990.
14. Hudson, B.G., Reeders, S.T. and Tryggvason, K.: Type IV collagen: structure, gene organization, and role in human diseases. J. Biol. Chem. 268: 26033-26036, 1993.
15. Jakubowski, M.: Receptor mRNA measurements by multiplex nuclease protection assay. In: Methods in Neurosciences, Academic Press, San Diego, 1995, pp. 470-491.
16. Kalluri, R., Shield, C.F., Todd, P., Hudson, B.G. and Neilson, E.G.: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest. 99: 2470-2478, 1997.
17. Kashtan, C.E., Atkin, C.L., Gregory, M.C. and Michael, A.F.: Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney Int. 36: 669-674, 1989.
18. Kashtan, C.E. and Kim, Y.: Distribution of the the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int. 42: 115-126, 1992.
19. Kleppel, M.M., Kashtan, C.E., Butkowski, R.J., Fish, A.J. and Michael, A.F.: Alport familial nephritis: Absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane. J. Clin. Invest. 80: 263-266, 1987.
20. Kleppel, M.M., Kashtan, C.E., Santi, P.A., Wieslander, J. and Michael, A.F.: Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab. Invest. 61: 278-289, 1989a.
21. Kleppel, M.M. and Michael, A.F.: Expression of novel basement membrane components in the developing human kidney and eye. Am. J. Anat. 187: 165-174, 1990.
22. Kleppel, M.M., Santi, P.A., Cameron, J.D., Wieslander, J. and Michael, A.F.: Human tissue distribution of novel basement membrane collagen. Am. J. Pathol. 134: 813-825, 1989b.
23. Leinonen, A., Mariyama, M., Mochizuki, T., Tryggvason, K. and Reeders, S.T.: Complete primary structure of the human type IV collagen α4(IV) chain. Comparison with structure and expression of the other α(IV) chains. J. Biol. Chem. 269: 26172-26177, 1994.
24. Lemmink, H.H., Kluijtmans, L.A.J., Brunner, H.G., Schröder, C.H., Knebelmann, B., Jelínková, R., Oost, B.A., Monnens, L.A.H. and Smeets, H.J.M.: Aberrant splicing of the COL4A5 gene in patients with Alport syndrome. Hum. Mol. Genet. 3: 317-322, 1994.
25. Lemmink, H.H., Schröder, C.H., Monnens, L.A.H. and Smeets, H.J.M.: The clinical spectrum of type IV collagen mutations. Hum. Mutation 9: 477-499, 1997.
26. Marinkovich, M.P., Keene, D.R., Rimberg, C.S. and Burgeson, R.E.: Cellular origin of the dermal-epidermal basement membrane. Develop. Dynam. 197: 255-267, 1993.
27. Mariyama, M., Leinonen, A., Mochizuki, T., Tryggvason, K. and Reeders, S.T.: Complete primary structure of the human α3(IV) collagen chain: Coexpression of the α3(IV) and α4(IV) collagen chains in human tissues. J. Biol. Chem. 269: 23013-23017, 1994.
28. Mariyama, M., Zheng, K., Yang-Feng. T.L. and Reeders, S.T.: Colocalization of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 13: 809-813, 1992.
29. McIntosh, I., Hamosh, A. and Dietz, H.C.: Nonsense mutations and diminished mRNA levels. Nat. Genet. 4: 219, 1993.
30. Miner, J.H. and Sanes, J.R.: Collagen IV α3(IV), α4(IV) and α5(IV) chains in rodent basal aminae: sequence, distribution, association with laminins, and developmental swiitches. J. Cell Biol. 127: 879-891, 1994.
31. Miner, J.H. and Sanes, J.R.: Molecular and functional defects in kidneys of mice lacking collagen α3: implications for Alport syndrome. J. Cell Biol. 135: 1403-1413, 1996.
32. Mochizuki, T., Lemmink, H.H., Mariyama, M., Antignac, C., Gubler, M.C., Pirson, Y., Verellen-Dumoulin, C., Chan, B., Schroeder, C.H., Smeets, H.J.M. and Reeders, S.T.: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat. Genet. 8: 77-82, 1994.
33. Myers, J.C., Howard, P.S., Jelen, A.M., Dion, A.S. and Macarak, E.J.: Duplication of type IV collagen COOH-terminal repeats and species-specific expression of α and α2(IV) collagen genes. J. Biol. Chem. 262: 9231-9238, 1987.
34. Myers, J.C., Jones, T.A., Pohjolainen, E-R., Kadri, A.S., Goddard, A.D., Sheer, D., Solomon, E. and Pihlajaniemi, T.: Molecular cloning of α5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. Am. J. Hum. Genet. 46: 1024-1033, 1990.
35. Nakanishi, K., Yoshikawa, N., Iijima, K., Kitagawa, K., Nakamura, H., Ito, H., Yoshioka, K., Kagawa, M. and Sado, Y.: Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int. 46: 1413-1421, 1994.
36. Nakanishi, K., Yoshikawa, N., Iijma, K. and Nakamura, H.: Expression of type IV collagen α3 and α4 chain mRNA in X-linked Alport syndrome. J. Am. Soc. Nephrol. 7: 938-945, 1996.
37. Ninomiya, Y., Kagawa, M., Iyama, K., Naito, I., Kishiro, Y., Seyer, J.M., Sugimoto, M., Oohashi, T. and Sado, Y.: Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J. Cell Biol. 130: 1219-1229, 1995.
38. Oberäumer, I. and Speth, C.: Evaluation of mRNA steady-state and protein levels for basement membrene proteins in cultured murine cells. Cell Tissue Res. 268: 439-445, 1992.
39. Olsen, D.R., Peltonen, J., Jaakkola, S., Chu, M.-L. and Uitto, J.: Collagen gene expression by cultured skin fibroblasts: Abundant steady-state levels of type VI procollagen messenger RNAs. J. Clin. Invest. 83: 791-795, 1989.
40. Olsen, D.R. and Uitto, J.: Differential expression of type IV procollagen and laminin genes by fetal vs adult skin fibroblasts in culture: determination of subunit mRNA steady-state levels. J. Invest. Dermatol. 93: 127-131, 1989.
41. Peissel, B., Geng, L., Kalluri, R., Kashtan, C.E., Rennke, H.G., Gallo, G.R., Yoshioka, K., Sun, M.J., Hudson, B.G., Neilson, E.G. and Zhou, J.: Comparative distribution of the α1(IV), α5(IV) and α6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J. Clin. Invest. 96: 1948-1957, 1995.
42. Penadés, J.R., Bernal, D., Revert, F., Johansson, C., Fresquet, V.J., Cervera, J., Wieslander, J., Quinones, S. and Saus, J.: Characterization and expression of multiple alternatively spliced ranscripts of the Goodpasture antigen gene region: Goodpasture antibodies recognize recombinant proteins representing the autoantigen and one of its alternative forms. Eur. J. Biochem. 229: 754-760, 1995.
43. Pihlajaniemi, T., Tryggvason, K., Myers, J.C., Kurkinen, M., Lebo, R., Cheung, M.C., Prockop, D.J. and Boyd, C.D.: cDNA clones coding for the pro-α1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain. J. Biol. Chem. 260: 7681-7687, 1985.
44. Schmidt, C., Pollner, R., Pöschl, E. and Kühn, K.: Expression of human collagen type IV gene is regulated by transcriptional and post-transcriptional mechanisms. FEBS 312: 174-178, 1992.
45. Thorner, P.S., Zheng, K., Kalluri, R., Jacobs, R. and Hudson, B.G.: Coordinate gene expression of the α3, α4 and α5 chains of collagen IV: evidence from a canine model of X-linked nephritis with a COL4A5 mutation. J. Biol. Chem. 271: 13821-13828, 1996.
46. Willing, M.C., Deschenes, S.P., Slayton, R.L. and Roberts, E.J.: Premature chain termination is a unifying mechanism for COL4A1 null alleles in osteogenesis imperfecta type I cell strains. Am. J. Hum. Genet. 59: 799-809, 1996.
47. Yoshioka, K., Hino, S., Takemura, T., Maki, S., Wieslander, J., Takekoshi, Y., Makino, H., Kagawa, M., Sado, Y. and Kashtan, C.E.: Type IV collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am. J. Pathol. 144: 986-996, 1994.
48. Zhang, Z-X., Wakamatsu, N., Mules, E.H., Thomas, G.H. and Gravel, R.A.: Impact of premature stop codons on mRNA levels in infantile Sandhoff disease. Hum. mol. Genet. 3: 139-145, 1994.
49. Zheng, K., Thorner, P.S., Marrano, P., Baumal, R. and Mclnnes, R.R.: Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc. Natl. Acad. Sci. USA 91: 3989-3993, 1994.
50. Zhou, J., Barker, D.F., Hostikka, S.L., Gregory, M.C. and Atkin, C.L.: Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9: 10-18, 1991.
51. Zhou, J., Ding, M., Zhao, Z. and Reeders, S.T.: Complete primary structure of the sixth chain of human basement membrane collagen, α6(IV): Isolation of the cDNAs for α6(IV) and comparison with five other type IV collagen chains. J. Biol. Chem. 269: 13193-13199, 1994a.
52. Zhou, J., Leinonen, A. and Tryggvason, K.: Structure of the human type IV collagen COL4A5 gene. J. Biol. Chem. 269: 6608-6614, 1994b.